More than 15,000 children are diagnosed with cancer annually. To save their child’s life, parents often have to consent to toxic therapies that will most likely lead to devastating, lifelong side effects.
As a corporate partner, we invite your company to join us in the fight for safer, more effective treatments for children with cancer. Your support not only benefits childhood cancer research, but also engages your employees, adds to your company’s social responsibility, and creates a unique marketing story to share with your community.
Email us today to get started with creating your custom corporate partnership. We look forward to working with you!
CORPORATE PARTNERS
Kiewit Corporation sponsors and hosts annual Jakefest golf tournaments across the country, in addition to sponsoring the Denver CureSearch Walk.
Iron Hill Brewery and Restaurant has raised nearly $200,000 for CureSearch through their Triple Chocolate Hill Dessert Program. Each time someone orders a Triple Chocolate Hill dessert, Iron Hill donates 75 cents to CureSearch.
Since 2019, Busy Bee has partnered with CureSearch to raise funds in their award-winning travel centers throughout Florida and Southern Georgia, giving customers the opportunity to round up their gas, food and beverage purchases to support childhood cancer research.
CureSearch partners with the Mattel Children's Foundation to provide special bald Brave Barbies to childhood cancer patients. Brave Barbie helps children better understand their hair loss and provides a "friend" through treatment and beyond.
Parexel sponsors the My CureSearch Walk, and is also represented on the CureSearch Industry Advisory Council.
Vensure hosts an annual Childhood Cancer Awareness Month fundraising campaign, engaging employees, customers and the community to support childhood cancer research.
Nelson Mullins' expert attorneys generously provide our staff with pro-bono legal support.
STRATEGIC SUPPORTERS
Our Strategic Supporters provide critical funding and/or expertise to advance our programmatic initiatives aimed at driving collaboration across the pediatric cancer ecosystem to accelerate the pace of new drug development.
